Mangalam Cement Weak volumes marred performance



Similar documents
Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, Target Price Rs220. IT India.

Shriram Transport Finance Subsidiaries witness sharp increase in NPA

YES Bank HOLD. Not out of the woods yet; Asset quality remains a key monitorable. Institutional Equity Research. January 30, Target Price Rs788

Simplex Infrastructures

Flexituff International Ltd. (FIL)

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

Techno Electric & Engineering Limited

Tree House Education & Accessories

Gujarat State Petronet Ltd. INR 135

Strong operational performance

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

Higher other income drive the quarter

Results impacted by subdued demand

GAIL (India) Ltd. INR 346

HCC BUY. Infrastructure January 29, 2016

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

UltraTech Cement Ltd.

Navin Fluorine International

Maruti Suzuki. Source: Company Data; PL Research

The Ramco Cements. Source: Company Data; PL Research

RamKrishna Forgings Ltd.

East India Hotels (EIH) Ltd Growing Strategically

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

GlaxoSmithKline Consumer Healthcare

Britannia Industries

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers

Minda Industries Ltd. INR 886

BUY RSWM LTD SYNOPSIS. CMP Target Price SEPTEMBER 1 st Result Update(PARENT BASIS): Q1 FY16

Company Overview. Financial Performance

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Pidilite Industries. Source: Company Data; PL Research

Bata India Ltd. (BIL)

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP Target Price JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights

Bharat Earth Movers (BEML)

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16

Va Tech Wabag. Source: Company Data; PL Research

Granules India Ltd. INR 113

HOLD ASTRAL POLYTECHNIK. Q3 muted; recovery ahead. Target Price: Rs 377. Key highlights. Key drivers

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins

BUY. Lower realization impacts earnings CAIRN INDIA. Target Price: Rs 155. Analyst call highlights

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research

HCL Technologies BUY. Performance Highlights CMP. `857 Target Price `1,132. 1QFY2016 Result Update IT. 3-year price chart

Smruthi Organics Limited BSE Scrip Code:

Butterfly Gandhimathi (GANAP) 188

How To Understand And Value Gsk Pharma

Cipla Ltd. Rs India Equity Institutional Research Pharma. One off revenues from Nexium supply drives earnings HOLD. Target Price (Rs): 765

Jubilant Life Sciences

Kotak Mahindra Bank Rs 685

Just Dial Ltd Bloomberg Code: JUST IN

Axis Bank. Strong core performance. Source: Company Data; PL Research

SAIL (SAIL) 56. Dismal performance. Result Update. ICICI Securities Ltd Retail Equity Research. August 17, 2015

Khambatta Securities Ltd.

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Wipro BUY. Performance Highlights CMP. `573 Target Price `719. 2QFY2016 Result Update IT. Investment Period 12 Months. 3-year price chart

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold

BUY. JYOTHY LABORATORIES LTD Result Update (CONSOLIDATED BASIS): Q2 FY16. CMP Target Price DECEMBER 29 th 2015.

BUY. Key Risks. Technology - Technology Services - Information Services. Nov 19, CRISIL Ltd. Recommendation (Rs.)

SECTOR: REALTY REPORTING DATE: 31 ST MAY, 2016 PVP Ventures Ltd

Larsen & Toubro. Source: Company Data; PL Research

BUY. ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16. CMP Target Price SEPTEMBER 2 nd, 2015 SYNOPSIS ISIN: INE738I01010

How To Value Hpl In India

Mahindra CIE Automotive Ltd.

HEG Ltd (HEG) 160. Performs well. Result Update. ICICI Securities Ltd Retail Equity Research. November 10, 2015

CD Equisearch Pvt Ltd

CMP: JUNE 2016 SWARAJ ENGINES LTD

Kingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3.

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Rating Change 1 February 2016

India Equity Research Telecommunications September 2, 2015 Management Meet Update

Margins to remain in mid 15% range for FY 16E, increase in FY 17E on operating leverage

Outlook and valuation

DATRON AG. Investor day supports our positive view. Buy (Buy) EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

infotech.com SECTOR: IT SOFTWARE REPORTING DATE: 31 ST MAY, i Infotech Ltd.

Exhibit 1: Financial summary of First Tractor in 1H12-1H14 1H12 2H12 1H13 2H13 1H14 (% YoY)

Prospect Capital Corporation (NASDAQ: PSEC)

2 September 2015 YOC AG. FIRST BERLIN Equity Research

SOHO China (410) Buy Nov 20, Company update. 4 Acquisitions within 6 Months. Samson Man, CFA (852) samson.man@firstshanghai.com.

Investment Rationale

BDI BioEnergy Intern Neutral. Activity level in Q3 might not support FY estimates

FY08 FY09 FY10 FY11E FY12E FY13E FY14E FY15E

Private drilling fluid technology service leader

Bharti Infratel (BHAINF) 370

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

Systematix Institutional Equities

Kajaria Ceramics HOLD. Robust Q2 but rich valuations downgrade to HOLD. Results Review INDIA TP: INR % KJC IN

Transcription:

CMP* (Rs) 206 Market Cap. (Rs bn) 5.5 Free Float (%) 72 Shares O/S (mn) 26.7 Mangalam Cement Weak volumes marred performance Mangalam Cement (MCL) delivered a weak performance in 2Q but was marginally above our expectation as operating profit (adjusted for DMF provisioning of Rs45mn and wage board revision of Rs38mn) came in at Rs84mn v/s expectation of Rs56mn. Weak sales volume (down ~14% yoy) and ~3% yoy decline in average realizations marred the operating performance. Given the current market feedback from our dealers check, we do not expect any encouraging scenario in demand in 3QFY16E. Nonetheless, we believe that performance from 4QFY16E is likely to improve due to: 1) likely improvement in pricing environment, 2) healthy volume growth along with pickup in utilizations from new units, 3) sales tax subsidy, 4) softened fuel costs owing to improving efficiency of plants, and 5) change in production mix (MCL has guided to take PPC production to ~70% from ~60%). Thus, we maintain our recommendation on the stock with a revised Target Price of Rs250. Dismal sales volume led to revenue de-growth MCL reported a top-line de-growth of ~16% yoy to ~Rs2bn, which is in-line with our estimate. A significant decline in sales volume (down by ~14% yoy to 0.55mnT) led to decline in revenue. MCL sold ~30,000 tonnes of cement from the leased unit in Ghaziabad during the quarter. MCL has produced 0.27mnT clinker during 2Q v/s 0.48mnT and 0.49mnT production recorded during 2QFY15 and 1QFY16, respectively. Operating performance remained subdued Operating performance remained subdued as operating profit (adj for DMF provisioning of Rs45mn and wage board revision of Rs38mn) came in at Rs84mn (down ~61% yoy). Dismal volume and low realizations impacted operating performance. Notably, low utilization also led to increase in operating cost/tonne (up ~2% yoy and ~3% qoq). Adjusted EBITDA/tonne came in at Rs161 as against Rs337 reported in 2QFY15. Outlook and Valuation We expect MCL s performance to improve from 4QFY16E on the back of expected pickup in demand and pricing scenario. However, we cut our EBITDA estimates by ~54%/~12% for FY16E/FY17E, respectively mainly to factor subdued volume, one time provisioning and dismal realizations. At the CMP, the stock is trading at EV/tonne of US$44/US$43 per tonne for FY16E/FY17E, which appears attractive. We reiterate our recommendation on the stock with a revised Target Price of Rs250 (implying EV/tonne at US$49 for FY17E).. Share price (%) 1 mth 3 mth 12 mth Absolute performance (7.8) (14.0) (31.4) Relative to Nifty (2.9 (9.3) (31.5) Shareholding Pattern (%) Jun 15 Sept 15 Promoter 27.5 27.6 FII 9.7 10.1 DII 4.3 4.3 Others 58.5 58.1 1 Year Stock Price Performance 400 350 300 250 200 150 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Note: * CMP as on November 09, 2015 Key Financials (Rs mn) FY14 FY15 FY16E FY17E Sales 6,973 9,218 9,185 11,529 EBITDA 557 904 475 1,638 Net Profit 296 179 (236) 643 EPS (Rs) 11.1 6.7 (8.8) 24.1 DPS (Rs) 3.0 2.0-2.0 PE (x) 18.6 30.7 (23.3) 8.6 P/B (x) 1.1 1.1 1.1 1.0 EV/EBITDA (x) 15.0 9.8 19.0 5.4 RoE (%) 5.9 3.5 (4.6) 12.2 Divi. Yield (%) 1.5 1.0-1.0 Source: Company, RSec Research Research Analyst : Binod Modi Contact : (022) 33201097 Email : binod.modi@relianceada.com 1

Risk to the view ff Government s failure to revive infrastructure activity Exhibit 1: Quarterly Performance (Rs mn) 2QFY16 2QFY15 % yoy 1QFY16 % qoq 1HFY16 1HFY15 % yoy Net Sales 1,999 2,378 (15.9) 2,114 (5.4) 4,113 4,659 (11.7) Cost of Materials Consumed 336 377 (10.7) 416 (19.1) 752 706 6.6 Purchase of stock in trade 122 187 (34.8) 141 (13.8) 263 338 (22.3) Change in WIP 291 (32) (75) 216 (37) % sales 37.5 22.4 22.8 29.9 21.6 Employee Benefit Expenses 169 133 27.6 169 0.1 338 260 29.9 % sales 8.5 5.6 8.0 8.2 5.6 Power & Fuel 358 652 (45.0) 629 (43.0) 987 1,201 (17.8) % sales 17.9 27.4 29.8 24.0 25.8 Packing, Distribution & Selling Exps. 565 671 (15.8) 664 (14.8) 1,229 1,282 (4.1) % sales 28.3 28.2 31.4 29.9 27.5 Other Expenditures 152 176 (13.5) 211 (27.8) 363 340 6.6 % sales 7.6 7.4 10.0 8.8 7.3 Total Expenditures 1,994 2,164 (7.8) 2,155 (7.4) 4,149 4,090 1.4 Operating costs/tonne (Rs) 3,467 3,393 2.2 3,367 3.0 3,484 3,280 6.2 EBITDA 5 215 (97.7) (41) (36) 569 (106.3) EBITDA/tone (Rs) 161 337 (52.2) (64) (351.4) (30) 456 (106.6) EBITDA margins 0.3 9.0 (1.9) (0.9) 12.2 Depreciation 89.6 89 1.0 87.0 2.9 177 159 10.9 Finance Costs 106.6 103 3.2 106.1 0.5 213 170 25.0 Other Income 9.5 31 (69.0) 26.6 (64.3) 36 61 (40.6) Exceptional Items 0.0 0 0.0 0 34 PBT (182) 53 (440.2) (207) (12.5) (389) 266 (246.4) Tax Expenses (26) 7 (479.3) (19) 38.0 (45) 90 % PBT 10.0 13.0 9.2 11.7 33.8 PAT (155) 46 (188) (344) 176 Net margins (7.8) 2.0 (8.9) (8.4) 3.8 EPS (Rs) (0.3) 1.7 (0.3) 6.59 Adjusted PAT (99) 46.5 (188.4) (288) 199 Source: Company, RSec Research Exhibit 2: Revised v/s Old estimates FY16E FY17E Old Revised % change Old Revised % change Volume (mnt) 2.7 2.5 (6.1) 3.0 2.9 (4.1) Sales (Rs mn) 10,129 9,185 (9.3) 12,375 11,529 (6.8) Realizations (Rs/tonne) 3,762 3,629 (3.5) 4,059 3,942 (2.9) EBIDTA (Rs mn) 1,021 475 (53.5) 1,869 1,638 (12.4) Margins (%) 10.1 5.2 (491 bps) 15.1 14.2 (90 bps) PAT (Rs mn) 191 (236) (223.4) 826 643 (22.2) EPS (Rs) 7.2 (8.8) (223.4) 30.9 24.1 (22.2) Source: RSec Research 2

Profit & Loss Statement Y/E March (Rs mn) FY14 FY15 FY16E FY17E Net Sales 6,973 9,218 9,185 11,529 % yoy growth (1.2) 32.2 (0.4) 25.5 Total Cost 6,416 8,314 8,710 9,891 Raw Materials Consumed 1,438 1,253 2,204 2,421 Employee Cost 426 577 579 715 Power & Fuel 1,715 2,584 2,492 2,830 Selling and Distribution Exp. 2,092 2,563 2,792 3,118 Other Expenditures 594 694 643 807 EBITDA 557 904 475 1,638 EBITDA Margin (%) 8.0 9.8 5.2 14.2 Depreciation and Amortization 277 336 385 442 Interest 87 383 434 439 Other Income 46 39 49 47 Exceptional Items 34 PBT 239 190 (295) 803 Tax (57) 11 (59) 161 % Tax (23.7) 5.6 20.0 20.0 Excep. Items - - - - Net Profit 296 179 (236) 643 YoY Growth (%) (61.7) (39.5) (231.8) (372.1) Net Profit Margin (%) 4.2 1.9 (2.6) 5.6 3

Balance Sheet Y/E March (Rs mn) FY14 FY15 FY16E FY17E Share Capital 267 267 267 267 Reserves & Surplus 4,803 4,909 4,723 5,302 Total Shareholder's funds 5,070 5,176 4,990 5,569 Secured Loans 3,680 4,032 4,232 4,132 Unsecured Loans - - - - Total Debt 3,680 4,032 4,232 4,132 Other Liabilities 797 803 1,007 1,295 TOTAL LIABILITIES 9,547 10,011 10,229 10,996 Gross Block 8,716 11,479 11,879 12,679 Less: Accumulated Depreciation 3,566 3,912 4,298 4,740 Net Block 5,150 7,567 7,581 7,939 CWIP 2,550 308 700 800 Investments 356 358 358 358 Inventories 1,159 1,585 1,409 1,706 Sundry Debtors 227 288 327 379 Cash & Bank 464 287 339 420 Loans & Advances 1,143 1,351 1,510 1,579 Total Current Assets 2,993 3,511 3,585 4,084 Current Liabilities 1,093 1,544 1,718 1,951 Provisions 172 158 166 188 Net Current Assets 1,727 1,809 1,701 1,944 Net Deferred Tax (610) (614) (614) (614) Other Assets 374 584 503 569 Total Assets 9,547 10,011 10,229 10,996 4

Cash Flow Statement Y/E March (Rs mn) FY14 FY15 FY16E FY17E Net Profit before Tax & Extraordinary Items 239 224 (295) 803 Depreciation 277 336 385 442 Interest (Net) 87 383 434 439 Dividend Received (46) (28) - - Others (18) (6) 51 - Operating profit before WC Changes 539 909 575 1,684 Working Capital Changes 193 (429) 160 (162) Direct Tax (102) 38 59 (161) Extraordinary Items - (34) - - Net Cash from Operating Activities 630 483 794 1,361 Purchase of Fixed Assets (2,306) (527) (792) (900) Purchase of Investments - (400) - - Others 51 425 - - Cash from Investment Activities (2,255) (502) (792) (900) Proceeds from LT Borrowings 1,433 287 200 (100) Dividend Paid (186) (94) - (64) Interest Paid (82) (377) (434) (439) Others - 26 284 223 Cash from Financing Activities 1,164 (158) 50 (380) Net Inc/(Dec) in Cash and Cash Equivalent (461) (177) 52 81 Opening Cash 923 464 287 339 Closing Cash 464 287 339 420 5

Key Ratios Y/E March FY14 FY15 FY16E FY17E Valuation Ratio (x) P/E 18.6 30.7 (23.3) 8.6 P/CEPS 9.6 10.7 36.8 5.1 P/BV 1.1 1.1 1.1 1.0 EV/EBITDA 15.0 9.8 19.0 5.4 EV/Sales 1.2 1.0 1.0 5.4 EV/tonne (US$) 40.2 42.7 43.4 42.6 Dividend Payout (%) 27.0 29.8-8.3 Dividend Yield (%) 1.5 1.0-1.0 Per Share Data (Rs) EPS (Basic) 11.1 6.7 (8.8) 24.1 EPS (Diluted) 11.1 6.7 (8.8) 24.1 CEPS 21.5 19.3 5.6 40.6 DPS 3.0 2.0-2.0 Book Value 190 194 187 209 EBITDA/tone (Rs) 298 369 191 567 Returns (%) RoCE 3.8 5.9 1.4 11.7 RoE 5.9 3.5 (4.6) 12.2 Turnover ratios (x) Asset Turnover (Gross block) 0.8 0.8 0.8 0.9 Inventory (days) 61 63 56 54 Receivables (days) 12 11 13 12 Payables (days) 62 68 72 72 6

General Disclaimers: This Research Report (hereinafter called 'Report') is prepared and distributed by Reliance Securities Limited (RSL) for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purposes of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or offering of any investment / trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/ investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, affiliates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, affiliates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value securities referred to herein may be adversely affected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces affecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be affected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may affect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. Neither RSL nor the research analysts had any known direct /indirect conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made, during the preparation of this Report. Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. ISO 9001:2008: Reliance Securities Limited holds a certificate issued by BSI Management System India Pvt. Ltd to the effect that it operates a Quality Management System that complies with the requirements of ISO 9001:2008 for providing equity & equity derivative trading services through online trading system. Investment in securities market is subject to market risk. Please read the risk disclosure document before investing. Reliance Securities is a distributor for MF, IPO, Bonds, NCDs and Corporate FDs Registered Office: Reliance Securities Limited, 11th Floor, R-Tech IT Park, Western Express Highway, Goregaon (East), Mumbai - 400063. Tel: +91 22 3320 1212, CIN: U65990MH2005PLC154052. (NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 011234839; AMFI ARN No.29889). 7